evidencegaps
Primary study · included by 1 review

8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.

Gonçalves 2020 · Goncalves Decia, Rebelo Virginia, Barbosa Paula, et al. · Pain physician · 2020

Included by

Capsaicin for Orofacial Pain Management: Systematic Review and Meta-Analysis.
Non-Cochrane · intervention · 2026 · cited as Goncalves 2020 · Figures 8 to 13; Supplementary File S5; reference list
Outcome this study informsPooled effectEvidenceCertainty
Orofacial pain intensity (VAS 0 to 10)
Capsaicin (topical 0.025% or 0.05% cream/gel, 8% patch) vs Pre-treatment baseline (same patients; uncontrolled single-arm studies) · End of treatment (final assessment)
MD -6.39 [-7.40, -5.38]3 studies · 26 participantsLow
Orofacial pain intensity (VAS 0 to 10)
Capsaicin (topical 0.025% or 0.05% cream/gel, 8% patch) vs Pre-treatment baseline (same patients; uncontrolled single-arm studies) · 12 weeks
MD -6.10 [-7.49, -4.71]2 studies · 14 participantsGRADE not reported

Also linked to PM42653103-P4-O2, which does not match a current question in this review.

1 including review in total.